European Space Agency Tackles Vision Loss in Astronauts

+AI Analysis - Key Points
- 01
The agency is commissioning Siloton to develop a solution for spaceflight-associated neuro-ocular syndrome (SANS)
- 02
SANS causes eye and brain changes due to prolonged periods in low-gravity environments
- 03
Astronauts on long missions face serious health risks, including permanent vision damage
The European Space Agency (ESA) is taking steps to address a pressing concern for astronauts: vision loss in space. The agency has commissioned British startup Siloton to develop a solution for spaceflight-associated neuro-ocular syndrome (SANS), a condition that affects around 70% of astronauts on the International Space Station.
SANS is a collection of eye and brain changes caused by spending prolonged periods in a low-gravity environment. The condition can lead to permanent vision damage, and astronauts on long missions face serious health risks. To mitigate this, the ESA is working with Siloton to develop a solution that can be used in space.

Silton is a health tech company that uses quantum technology to shrink core components used in eye-testing equipment. The company is currently working with the UK's National Health Service to enable patients with retinal conditions to self-scan at home. The ESA has similar requirements, but in a different environment.
The agency is concerned about the operational risk of astronauts losing their vision mid-mission, as well as the longer-term health impacts. Medical engineers want to develop their understanding of the condition and the factors causing it so that they can manage any ocular damage, and eventually treat it or even stop it from becoming a problem.
Scientists are already monitoring how spaceflight impacts the human eye on the ISS using a modified version of the device found in optometry offices. However, the device is bulky and requires real-time remote guidance from experts on the ground. As astronauts journey further into deep space, lengthening missions will only heighten the risk of permanent vision damage.
The ESA is taking a proactive approach to addressing this issue, and Siloton's solution could be a crucial step in preventing vision loss in astronauts. With the Artemis flights to the moon and other deep space missions on the horizon, the need for a solution is urgent.
The ESA is working closely with Siloton to develop a solution that can be used in space. The company's technology has the potential to revolutionize eye care in space, and the ESA is eager to see the results. With the help of Siloton, the ESA may be able to prevent vision loss in astronauts and ensure the success of future space missions.
VideoVideo Coverage
European Space Agency Tackles Vision Loss in Astronauts
Watch video coverage on YouTube
Opens relevant video results on YouTube.